Paul Hesketh to Karnofsky Performance Status
This is a "connection" page, showing publications Paul Hesketh has written about Karnofsky Performance Status.
Connection Strength
0.067
-
Hesketh PJ, Chansky K, Lau DH, Doroshow JH, Moinpour CM, Chapman RA, Goodwin JW, Gross HM, Crowley JJ, Gandara DR. Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027). J Thorac Oncol. 2006 Jul; 1(6):537-44.
Score: 0.067